日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Entrepreneurial migrants from/in emerging economies: breaking taboos and stereotypes

来自/身处新兴经济体的创业移民:打破禁忌和刻板印象

Smith, Lisa L; Flowe, Heather D; Kanja, Wangu; Guerrero, Maribel; Wanjiru, Roseline

Eμ-TCL1xMyc: A Novel Mouse Model for Concurrent CLL and B-Cell Lymphoma

Eμ-TCL1xMyc:一种新型的慢性淋巴细胞白血病和B细胞淋巴瘤并发小鼠模型

Lucas, Fabienne; Rogers, Kerry A; Harrington, Bonnie K; Pan, Alexander; Yu, Lianbo; Breitbach, Justin; Bundschuh, Ralf; Goettl, Virginia M; Hing, Zachary A; Kanga, Parviz; Mantel, Rose; Sampath, Deepa; Smith, Lisa L; Wasmuth, Ronni; White, Danielle K; Yan, Pearlly; Byrd, John C; Lapalombella, Rosa; Woyach, Jennifer A

BTK(C481S)-Mediated Resistance to Ibrutinib in Chronic Lymphocytic Leukemia

BTK(C481S)介导的慢性淋巴细胞白血病对伊布替尼的耐药性

Woyach, Jennifer A; Ruppert, Amy S; Guinn, Daphne; Lehman, Amy; Blachly, James S; Lozanski, Arletta; Heerema, Nyla A; Zhao, Weiqiang; Coleman, Joshua; Jones, Daniel; Abruzzo, Lynne; Gordon, Amber; Mantel, Rose; Smith, Lisa L; McWhorter, Samantha; Davis, Melanie; Doong, Tzyy-Jye; Ny, Fan; Lucas, Margaret; Chase, Weihong; Jones, Jeffrey A; Flynn, Joseph M; Maddocks, Kami; Rogers, Kerry; Jaglowski, Samantha; Andritsos, Leslie A; Awan, Farrukh T; Blum, Kristie A; Grever, Michael R; Lozanski, Gerard; Johnson, Amy J; Byrd, John C

Etiology of Ibrutinib Therapy Discontinuation and Outcomes in Patients With Chronic Lymphocytic Leukemia

慢性淋巴细胞白血病患者伊布替尼治疗中断的原因及预后

Maddocks, Kami J; Ruppert, Amy S; Lozanski, Gerard; Heerema, Nyla A; Zhao, Weiqiang; Abruzzo, Lynne; Lozanski, Arletta; Davis, Melanie; Gordon, Amber; Smith, Lisa L; Mantel, Rose; Jones, Jeffrey A; Flynn, Joseph M; Jaglowski, Samantha M; Andritsos, Leslie A; Awan, Farrukh; Blum, Kristie A; Grever, Michael R; Johnson, Amy J; Byrd, John C; Woyach, Jennifer A

Prolonged lymphocytosis during ibrutinib therapy is associated with distinct molecular characteristics and does not indicate a suboptimal response to therapy

伊布替尼治疗期间持续性淋巴细胞增多症与独特的分子特征相关,并不表明治疗反应不佳。

Woyach, Jennifer A; Smucker, Kelly; Smith, Lisa L; Lozanski, Arletta; Zhong, Yiming; Ruppert, Amy S; Lucas, David; Williams, Katie; Zhao, Weiqiang; Rassenti, Laura; Ghia, Emanuela; Kipps, Thomas J; Mantel, Rose; Jones, Jeffrey; Flynn, Joseph; Maddocks, Kami; O'Brien, Susan; Furman, Richard R; James, Danelle F; Clow, Fong; Lozanski, Gerard; Johnson, Amy J; Byrd, John C

Cyclophosphamide, alvocidib (flavopiridol), and rituximab, a novel feasible chemoimmunotherapy regimen for patients with high-risk chronic lymphocytic leukemia

环磷酰胺、阿沃西地(黄酮吡啶醇)和利妥昔单抗,是一种治疗高危慢性淋巴细胞白血病患者的新型可行化疗免疫疗法方案。

Stephens, Deborah M; Ruppert, Amy S; Maddocks, Kami; Andritsos, Leslie; Baiocchi, Robert; Jones, Jeffrey; Johnson, Amy J; Smith, Lisa L; Zhao, Yuan; Ling, Yonghua; Li, Junan; Phelps, Mitch A; Grever, Michael R; Byrd, John C; Flynn, Joseph M

Phase II study of flavopiridol in relapsed chronic lymphocytic leukemia demonstrating high response rates in genetically high-risk disease

一项针对复发性慢性淋巴细胞白血病患者的 II 期研究表明,flavopiridol 在遗传高危疾病中具有较高的缓解率。

Lin, Thomas S; Ruppert, Amy S; Johnson, Amy J; Fischer, Beth; Heerema, Nyla A; Andritsos, Leslie A; Blum, Kristie A; Flynn, Joseph M; Jones, Jeffrey A; Hu, Weihong; Moran, Mollie E; Mitchell, Sarah M; Smith, Lisa L; Wagner, Amy J; Raymond, Chelsey A; Schaaf, Larry J; Phelps, Mitch A; Villalona-Calero, Miguel A; Grever, Michael R; Byrd, John C

Prolonged myelosuppression with clofarabine in the treatment of patients with relapsed or refractory, aggressive non-Hodgkin lymphoma.

氯法拉滨治疗复发或难治性侵袭性非霍奇金淋巴瘤患者时可引起长期骨髓抑制

Blum Kristie A, Hamadani Mehdi, Phillips Gary S, Lozanski Gerard, Johnson Amy J, Lucas David M, Smith Lisa L, Baiocchi Robert, Lin Thomas S, Porcu Pierluigi, Devine Steven M, Byrd John C

Characterization of the TCL-1 transgenic mouse as a preclinical drug development tool for human chronic lymphocytic leukemia

将TCL-1转基因小鼠作为人类慢性淋巴细胞白血病临床前药物开发工具进行表征

Johnson, Amy J; Lucas, David M; Muthusamy, Natarajan; Smith, Lisa L; Edwards, Ryan B; De Lay, Michael D; Croce, Carlo M; Grever, Michael R; Byrd, John C